Skip to content

Remote Ischaemic Conditioning (RIC) in Heart Failure

Effects of Chronic Remote Ischaemic Conditioning on Coronary and Peripheral Vascular Function in Patients With Heart Failure

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06616233
Acronym
ENRICH
Enrollment
60
Registered
2024-09-27
Start date
2024-04-08
Completion date
2025-10-31
Last updated
2024-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dilated Cardiomyopathy, Heart Failure With Preserved Ejection Fraction, Type 2 Diabetes

Brief summary

This study will test the impact of remote ischaemic conditioning combined with exercise on myocardial perfusion in patients with or at risk of heart failure

Detailed description

Heart failure (HF) is a disease which affects the heart's ability to pump or fill with blood. It can affect a person's quality of life and their ability to exercise. Recent work has shown that a reduction in the blood supply to the heart may contribute to the problem. It is therefore possible that improving the blood supply to the heart may help patients with HF. One possible way that this might be achieved is with a method called remote ischaemic conditioning (RIC). This involves placing a cuff on a person's arm (identical to a blood pressure cuff) and inflating it for a few minutes to reduce the blood flow in a person's arm. This is thought to release chemicals into the bloodstream which can have positive effects on the heart. This has been studied in patients with other forms of heart disease, but is yet to be tested properly in patients with heart failure. It is hypothesized that combining the RIC procedure with a low level of arm exercise may result in further improvements in the person's blood vessels and heart. This will be tested in a single-centre prospective study.

Interventions

DEVICERemote Ischaemic Conditioning with exercise

Participants will receive RIC through an automated device that will provide cycles on ischaemia/reperfusion to the target organ (arm). During the cuff deflation phase, participants will undergo handgrip exercise at 20-30% of their maximal voluntary contraction for 3 minutes. There will be a total of 4 cycles of exercise.

DEVICEOther: Remote Ischaemic Conditioning

Participants will receive RIC through an automated device that will provide cycles on ischaemia/reperfusion to the target organ (arm).. There will be a total of 4 cycles.

Sponsors

Loughborough University
CollaboratorOTHER
University of Leicester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Blinded analysis of data

Intervention model description

Randomised trial of the effect of remote ischemic conditioning with or without lower intensity exercise on hyperaemic myocardial blood flow in patients with or at risk of heart failure.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age >18 years * Ability to provide written consent * clinical diagnosis of HFpEF (LVEF ≥50%; symptoms and signs of heart failure \[HF\] caused by a structural and/or functional abnormality, and at least one: elevated natriuretic peptides; ambulatory; BNP ≥35 pg/mL or NT-proBNP ≥125 pg/mL or hospitalised; BNP ≥100 pg/mL or NT-proBNP ≥300 pg/mL, and objective evidence of cardiogenic pulmonary or systemic congestion) OR stable type 2 diabetes (determined by formal diagnosis in hospital or GP case records with diagnostic oral glucose tolerance test or glycated haemoglobin level ≥6.5%) and with ACC/AHA stage B HF (structural disorder of the heart but no current or previous symptoms of HF) OR confirmed diagnosis of dilated cardiomyopathy

Exclusion criteria

* Absolute contraindications to MRI or contrast (e.g. severe claustrophobia, pregnancy, ferromagnetic implants, inability to lie flat, severe renal impairment eGFR<30ml/min/m2) * Moderate to severe valvular heart disease * Confirmed coronary artery disease (>50% narrowing in any major epicardial coronary artery on invasive or computed tomography coronary angiography, previous myocardial infarction, previous percutaneous intervention or coronary bypass surgery) * Known arterial stenosis of the upper extremity

Design outcomes

Primary

MeasureTime frameDescription
Myocardial perfusion reserve4 weeksmyocardial perfusion reserve under adenosine stress as assessed by quantitative cardiovascular magnetic resonance (CMR)
Contraction strength in the cuff deflation phase of RIC1 daycontraction force achieved during cuff deflation phase, measured in Newtons
Hyperaemic myocardial blood flow4 weeksmyocardial blood flow under adenosine stress as assessed by quantitative cardiovascular magnetic resonance (CMR)

Secondary

MeasureTime frameDescription
Skeletal muscle endurance4 weeksIsometric skeletal muscle endurance test assessed using handgrip dynamometer (sec)
Cardiopulmonary exercise test4 weeksVO2 max for maximal aerobic capacity
Brachial artery maximal dilatory capacity4 weeksendothelial function in response to Glyceryl trinitrate (GTN) as assessed by vascular ultrasound
Brachial artery flow mediated dilation4 weeksendothelial function as assessed by vascular ultrasound
Skeletal muscle strength4 weeksmaximal handgrip strength (newtons)

Countries

United Kingdom

Contacts

Primary ContactJayanth Arnold, BMBCh DPhil
jra14@leicester.ac.uk+44 1162583038
Backup ContactAaron Wiseman
aw520@leicester.ac.uk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026